Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: J Heart Lung Transplant. 2010 Apr 24;29(7):739–746. doi: 10.1016/j.healun.2010.03.003

Figure 3.

Figure 3

Figure 3

Figure 3a. Kaplan-Meier analysis of freedom from the development of advanced transplant coronary artery disease in pediatric cardiac transplant patients with PVB19-positive versus PVB19-negative EMBs. (p=0.01)

Figure 3b. Kaplan-Meier analysis of freedom from advanced transplant coronary artery disease in pediatric cardiac transplant patients with chronic parvovirus B19 (CPV) versus no history of parvovirus B19 (PV −) (p < 0.001) and acute parvovirus B19 (APV) versus PV − (p = 0.27)